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Obese pregnancies are not only associatedwith adverse consequences for themother but also the
long-term health of her child. Human studies have shown that individuals from obesemothers are
at increased risk of premature death from cardiovascular disease (CVD), but are unable to define
causality. This study aimed to determine causality using a mouse model of maternal diet–induced
obesity. Obesity was induced in female C57BL/6 mice by feeding a diet rich in simple sugars and
saturated fat6weeksprior topregnancyandthroughoutpregnancyand lactation.Control females
were fed laboratory chow.Male offspring fromboth groupswereweaned onto chow and studied
at 3, 5, 8, and 12weeks of age for gross cardiacmorphometry using stereology, cardiomyocyte cell
area by histology, and cardiac fetal gene expression using qRT-PCR. Cardiac function was assessed
by isolated Langendorff technology at 12 weeks of age and hearts were analyzed at the protein
level for the expression of the 1 adrenergic receptor, muscarinic type-2 acetylcholine receptor,
and proteins involved in cardiac contraction. Offspring from obese mothers develop pathologic
cardiac hypertrophy associated with re-expression of cardiac fetal genes. By young adulthood
these offspring developed severe systolic and diastolic dysfunction and cardiac sympathetic dom-
inance. Importantly, cardiac dysfunction occurred in the absence of any change in corresponding
bodyweightanddespite theoffspringeatingahealthy low-fatdiet. These findingsprovideacausal
link to explain human observations relating maternal obesity with premature death from CVD in
her offspring. (Endocrinology 155: 3970–3980, 2014)
The growingprevalence of obesity is posing a significantburden for future generations by increasing their risk
of noncommunicable diseases such as cardiovascular dis-
ease (CVD). Furthermore, obesity prevalence is increasing
globally including women of childbearing age (1). Al-
though obesity during pregnancy is associated with im-
mediate adverse pregnancy and neonatal outcomes (2, 3),
growing evidence from the field ofDevelopmentalOrigins
of Health and Disease suggests that early life insults (eg,
obesity, undernutrition, hypoxia), shapeourvulnerability
to disease (4, 5). There is strong indication from human
studies and animal models that exposure to obesity in
utero and early postnatal life increases risk of later CVD.
For example, in a recent study of 37 709 individuals, ma-
ternal obesity was associated with increased all-cause
mortality and admission to hospital for cardiovascular
events inheroffspring (6). Similarobservationsweremade
in a smaller Finnish cohort where maternal body mass
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index was associated with an increased risk of coronary
heart disease in the offspring (7).
Unfortunately, confounding factors in human studies
limit any inferences from such studies to pure association,
and this is where animalmodels ofmaternal overnutrition
and obesity have been invaluable in determining mecha-
nisms underlying programming. These models include
manipulation of the maternal diet such that it contains
either high fat (8–11), or is rich in both sugar and fat (12,
13), overfeeding by raising the recommended food intake
(14, 15), and genetic models of obesity (16). Exposure of
offspring to an overnourished and/or obesogenic environ-
ment in early life has been associatedwith later obesity (8),
endothelial dysfunction (10, 17, 18), elevated cholesterol
(19), hypertension (8, 9, 12, 19, 20), and cardiac hyper-
trophy (13, 18) in young adults. Whereas a number of
studies have shown that exposure to maternal overnutri-
tion and/or obesity programs an increased risk of CVD, as
well as obesity (8, 9, 12), the effect of such exposures on
offspring adult cardiac structure and function indepen-
dent of the offspring themselves developing obesity has
not been addressed. Because obesity itself is an indepen-
dent risk factor for CVD (21, 22), tackling this question
may elucidatemechanisms bywhich CVD is programmed
in the offspring of obese pregnancy via alternative path-
ways, thereby identifying novel therapeutic targets for in-
tervention. We investigated this in a well-established
model of maternal diet-induced obesity (13). The de-
velopment of cardiac hypertrophy was previously dem-
onstrated at 8 weeks of age in male offspring (13).
Therefore, using an integrated approach of assessing
both cardiac structure and molecular markers of car-
diac hypertrophy, male offspring exposed to maternal
diet-induced obesity were studied at 3, 5, 8, and 12
weeks of age. Importantly, molecular and structural
changes were identified within the context of develop-
ing impairments in cardiac function using the isolated
Langendorff heart perfusion preparation.
Materials and Methods
Animal model
All studieswere approved by the local ethics committee of the
University of Cambridge and were conducted according to the
Home Office Animals (Scientific Procedures) Act 1986 (United
Kingdom). At 3weeks of age female C57BL/6Jmice were placed
onto either an ad libitum control chow diet (RM1) [7% simple
sugars, 3% fat (wt/wt) (Special Dietary Services)] or a highly
palatable energy-rich obesogenic diet [10% simple sugars, 20%
animal lard (wt/wt) (Special Dietary Services)] supplemented
with sweetened condensed milk [approximately 55% simple
sugars, 8% fat, (wt/wt) (Nestle)] contained in a pot within the
female cage, and vitamin and mineral mix AIN93G (Special Di-
etary Services) for 6 weeks before mating. Breeding was per-
formed in house. A detailed breakdown of the dietary compo-
sition has been previously reported (12). Offspring from the first
pregnancy were culled at weaning, providing proven breeder
status. Females fed the obesogenic diet were mated for second
pregnancy once reaching 10 g absolute fat mass, confirming
prepregnancy obesity (Minispec Time Domain Nuclear Reso-
nance, Bruker Optics). On reaching 10 g fat mass or 1 week of
rest for control females, proven breeders were remated for sec-
ond pregnancy and maintained on their respective diets during
pregnancy and lactation. Dams were weighed at the beginning
and end of pregnancy and at the end of lactation. Litter size was
standardized at random to six pups 48hours post delivery,main-
taining an equal sex ratio where possible. Female offspring were
culled at weaning with males being studied at 3, 5, 8, and 12
weeks of age. In total there were 31 litters from control females
and 38 from obese females. Offspring from obese dams are la-
beled as offspring of obese dams (OffOb). Two littermates were
usedat each timepoint; theheart fromoneanimalwas frozenand
the other animal’s heart was fixed in 10% neutral buffered for-
malin (NBF). Offspring culled at day 22 (3 weeks old) were
weaned from their respective dam and fasted overnight. Off-
spring used for later time points (5, 8, and 12weeks of age) were
weaned ad libitium onto standard laboratory chow [RM1 (Spe-
cial Dietary Services)]. At 3, 5, and 8 weeks of age mice were
culled after an overnight fast by carbon dioxide asphyxiation.
Due to the requirements of the isolated Langendorff heart per-
fusion, offspring at 12weeks of age remained fed andwere culled
by cervical dislocation. The hearts used in the Langendorff heart
perfusion were fixed post procedure, whereas the heart of its
littermate was frozen.
Blood was allowed to clot and then centrifuged at 7200 g
(Eppendorff centrifuge 5424) for 3 minutes and the serum re-
moved. To enhance the yield, the supernatant was respun under
the same conditions and serum removed and frozen at 80 C
until analysis.Total cholesterol, triglycerides, and free fatty acids
were measured at the Core Biochemical Assay Laboratory (Ad-
denbrookes Hospital).
Cardiac stereology
Offspring hearts from all time pointswere fixed in 10%NBF,
processed, and embedded in paraffin. Serial sections were cut in
the coronal plane at 10 m using a microtome (Leica Microsys-
tems). Slides were processed and stained with hematoxylin and
eosin. SectionswerevisualizedusingaBX-50microscope (Olym-
pus) fitted with a motorized specimen stage and microcator.
Analyses were performed blinded using the Computer Assisted
Stereology Toolbox version 2.0 (Olympus). Wall and compart-
mental volumes (mm3) were calculated for the left ventricle (LV)
[(LV) combining the LV free wall and interventricular septum
and right ventricle (RV)] using the Cavalieri principle. Detailed
methodology has been described previously (13, 23).
Cardiomyocyte cross-sectional cell area
Wheat germ agglutinin was used to stain cardiomyocyte cell
borders at all time points using a previously described method
[TexasRed-Xconjugate, (Molecular Probes, LifeTechnologies)]
(13).Hearts weremounted onto a chuck in the orientation of the
heart in vivo using Tissue Tek optimal cutting temperature com-
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pound (Sakura). The heart was sectioned in the coronal plane at
21Cuntil reaching themid-cardiac region. Two7-msections
were cut consecutively and mounted onto a charged slide. Sec-
tionswere fixed in10%NBFfor20minutes at roomtemperature
and washed with phosphate buffered saline (PBS) before incu-
batingwith 10g/ml of conjugated agglutininwhile gently rock-
ing in darkness for 2hours at room temperature. Slideswere then
washed with PBS and air-dried before addition of Vectashield
mountingmediumwith 4=,6-Diamidino-2-phenylindole (Vector
Laboratories). Images were analyzed double-blinded using
CellD software (Olympus). Onlymyocytes in cross-section were
selected. Area was calculated by averaging across five separate
images per heart (approximately 400–600 cells measured per
heart).
Cardiac mRNA expression
At all time points, RNA was extracted from 30 mg of pow-
dered tissue from whole heart using the mirVANA isolation kit
as per themanufacturer’s instructions (Life Technologies). RNA
concentration (ng/ml) was quantified using the Nanodrop spec-
trophotometer (Nanodrop Technologies). cDNA synthesis was
performed using 1 g of RNA, oligo-dT primers, and Moloney
Murine Leukemia Virus reverse transcriptase (Promega). SYBR
green technology coupled with designed intron-spanning Sigma
primers were used to quantify gene expression (Sigma-Aldrich).
Primer sequences are listed in Supplemental Table 1. Gene ex-
pression was quantified using a Step One Plus RT-PCRmachine
(Applied Biosystems). mRNA expression was normalized to
housekeeper PPIA. There was no significant effect of either ma-
ternal diet or offspring age on mRNA expression of PPIA.
Isolated Langendorff heart perfusion
Basal cardiac function
At 12 weeks of age, fed mice were killed by cervical dislo-
cation. After recording of body weight, a thoracotomy was
performed and the heart was rapidly excised and immediately
placed into ice-cold Krebs-Henseleit bicarbonate (KHB) buf-
fer (120mM NaCl, 4.7mM KCl, 1.2mM MgSO2·7H2O,
1.2mMKH2PO4, 25mMNaHCO3, 10mMglucose, and1.3mM
CaCl2·2H2O). The heart was cannulated via the aorta and per-
fused via the coronary arteries whereas lung, mediastinal, and
pericardiac brown adipose tissue were dissected away. A pul-
monary arteriotomy was performed. Hearts were perfused at a
constant pressure of 65 mmHg (24). A small flexible nonelastic
balloon was inserted into the LV through the left atrium (LA).
The balloon was filled with deionized water and attached to a
rigid, deionized water-filled catheter connected to a calibrated
pressure transducer (ArgonMedical Devices). The volume of the
balloon was adjusted by injection of deionized water with a
100-L Hamilton syringe to get a recording of LV end diastolic
pressure (LVEDP) between 5 and 10 mmHg (25).
Recirculating KHB was filtered through a 5-m cellulose ni-
trate filter (Millipore) and gassed with O2:CO2 (95:5) at 37 C.
After an initial stabilization period of 15 minutes, basal mea-
surements of heart rate (HR), LV systolic pressure (LVSP) and
LVEDP were recorded. Baseline LV developed pressure (LVDP)
was calculated as LVSP-LVEDP. The maximum (dP/dtmax) and
minimum (dP/dtmin) first derivatives of LV pressure were calcu-
lated automatically using the M-PAQ data acquisition system
(Maastricht Programmable AcQusition System).
Treatment with parasympathetic and sympathetic
agonists
Cardiacchronotropicandinotropicresponsiveness tocarbachol
(carbamylcholinechloride; range,109–107M, [Sigma-Aldrich])
and isoprenaline [()-Isoproterenol ()-bitartrate salt; range,
1010–108 M (Sigma-Aldrich)] was investigated. Carbachol and
isoprenaline were dissolved in KHB and introduced into the heart
via the compliance chamber of the Langendorff apparatus. The
heart was perfused in a non-recirculating way to avoid accumula-
tion of carbachol or isoprenaline within the system. Recovery time
(ranging from 5–15 minutes) was allowed between each bolus to
allow HR and LVDP to stabilize to baseline values before the ad-
ministration of the next bolus.
Cardiac protein expression
Proteins critical for the inotropic and chronotropic action of
the heart were studied in fed tissue to establish underlyingmech-
anisms of cardiac dysfunction at 12 weeks of age. Protein ex-
pression was determined by Western blot, as previously de-
scribed (13). Protein (10 g) was loaded for each sample. Equal
protein loading was confirmed by Coomassie blue staining. An-
tibodies to the following proteinswere used:phosphorylated car-
diac troponin-I (serine 23/24); total troponin-I; ATP2A2/
SERCA2; tropomyosin-1 (all Cell Signaling); 1 adrenergic
receptor (Santa Cruz Biotechnology), Muscarinic type-2 acetyl-
choline receptor (Abcam). Horseradish peroxidise-linked sec-
ondary antibodies were used (Jackson ImmunoResearch). Pro-
tein bands were detected using West Pico Chemiluminescence
reagent (Pierce, Thermo Scientific). Membranes were either im-
aged using the Bio-Rad Chemi-doc MP system and analyzed
using Image Lab Software (Bio-Rad Laboratories) or exposed to
photosensitive film (GE Healthcare Amersham Hyperfilm ECL
[Fisher Scientific]) and analyzed using AlphaEase imaging soft-
ware (Alpha Innotech). To ensure the chemiluminescent signal
changed in a linear manner, the ratio between loading controls
(50% and 100% pooled sample) was confirmed for each de-
tected protein.
Statistical analysis
Data were analyzed using Prism 5 (GraphPad). Offspring
growth trajectory was plotted as an average body weight per
litter from day 3–84 and all litters used were included. Data
containing multiple time points were analyzed using a 2-way
ANOVA, with the exception of offspring growth trajectory,
which was analyzed using a repeated-measures 2-way ANOVA.
Holm Sidak post hoc correction was applied in the presence of a
significant (P  .05) overall effect of maternal diet or offspring
age. When comparing two groups at a single time point, an un-
paired t-test was used. With the exception of offspring growth
trajectory where the average body weight for each litter was
calculated, only one male per litter was used in any one analysis.
For all comparisons, P  .05 was considered statistically
significant.
Results
High-sugar, high-fat feeding in females increases
body weight and adiposity
Obesity was induced in female mice by feeding a high-
fat, high-sugardiet 6weeksprior to conceptionandduring
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pregnancy and lactation. Control females were fed a stan-
dard laboratory chow throughout. Concurrent with pre-
vious results (12, 13), dams fed the highly palatable obe-
sogenic diet were heavier before (33.3 1.2 g [n 12] vs
27.7  0.7 g [n  8], P  .01) and immediately after
parturition (35.20.9 g [n14] vs 32.40.5 g [n16],
P .01), and at weaning (41.3 1.6 g [n 14] vs 33.5
0.6 g [n16],P .001) comparedwith control dams. Fat
and lean mass was measured in dams at weaning by time-
domain nuclear magnetic resonance. Both absolute
(14.31.6 g vs3.40.3 g,P .001) and relative fatmass
as a percentage of body weight (34.5  2.7 % vs 12.1 
0.7 %, P  .001) were increased in dams fed the obeso-
genic diet. However, absolute lean mass was similar be-
tween groups (control dams, 19.8 0.3 g vs obese dams,
19.8  0.2 g).
Exposure to maternal obesity increased heart
weight and cardiomyoycte cell size independent
of offspring body weight
There was no effect of maternal diet on offspring
growth trajectory from 3–12 weeks of age (Figure 1A).
Also, there were no differences in retroperitoneal (con-
trols, 83  19 mg vs OffOb, 83  15 mg; n  8 and n 
7 per group, respectively) and epididymal fat pad weights
(controls, 373 46mg vsOffOb 448 57mg; n 8 and
n 7 per group, respectively) between groups at 12weeks
of age when cardiac function was assessed. Furthermore,
there was no overall effect of maternal diet on circulating
factors including total cholesterol, triglycerides, and free
fatty acids (Table 1).
Cardiac growth was accelerated in offspring of obese
dams relative to controlswith an effect ofmaternal diet on
both absolute (Figure 1B) and relative heart weight (Table
2). The most pronounced differences were observed at 3
and 8 weeks of age. However, by 12 weeks, heart weights
were similar in both groups.
To address whether the increased heart weight in off-
spring of obese dams was a consequence of cardiac re-
modelling, nonbiased cardiac stereology was performed
toassess both ventricularwall and chamber volumes. Both
LV and RV volumes were increased in offspring exposed
to maternal obesity (Table 2). Because there was evidence
of ventricular wall thickening, particularly in the LV, cell-
specific hypertrophy was addressed. Frozen sections from
the LV were stained with wheat germ agglutinin to high-
light the cardiomyocyte cell borders. Cell area was quan-
tified using computer-assisted software. In line with ven-
tricular wall thickening, cardiomyocyte cell hypertrophy
was observed in offspring of obese dams (Figure 1, C and
D). The increase in cell size wasmost pronounced at 3 and
8 weeks of age, however these differences were no longer
apparent by 12 weeks of age.
Re-expression of fetal genes indicative of
pathologic cardiac hypertrophy was observed in
offspring of obese dams
We further investigated whether the observed cardiac
hypertrophy was physiologic or pathologic. Cardiac fetal
genes (NPPA, NPPB, MYH6, MYH7 and ACTA1) are
usually only expressed during fetal life and re-expression
of these genes in adult life is an indicator of pathologic
cardiac hypertrophy (26). Increased mRNA expression of
cardiac NPPB (P  .05) and ACTA1 (P  .05) was ob-
served in offspring of obese dams relative to controls (Fig-
ure 2, A and B). In the healthy mouse heart, expression of
MYH6 predominates overMYH7 (27, 28); however, dur-
ing periods of cardiac stress there is a switch in ratio of
these two genes, whereby the energy-conservative -my-
osin heavy chain becomes more highly expressed. Our re-
sults demonstrated an increase in ratio ofMHY7:MYH6
in offspring of obese dams from weaning (Figure 2C).
There is evidence that this switch can negatively affect
cardiac function (29).
Baseline cardiac function is impaired in offspring
of obese dams by young adulthood with
evidence of sympathetic dominance, a
pre-eminent marker of heart failure
Confronted with evidence of pathologic cardiac hyper-
trophy at the structural and molecular levels in offspring
of obese dams, we assessed the potential effect on cardiac
function. This was measured in 12-week old offspring ex
vivo using the isolated Langendorff heart perfusion tech-
nique. Hearts from offspring of obese dams had systolic
dysfunction including reduced LV developed pressure
(LVDP) (P .01) and an impaired velocity of contraction
(dP/dtmax) (P  .05) relative to controls (Figure 3, A and
B). Hearts of offspring from obese pregnancy also showed
increasedLVenddiastolic pressure (LVEDP) (P .05), (Fig-
ure 3C), a well-established marker of diastolic dysfunction
(30). Furthermore, ventricular relaxation was impaired in
offspring of obese dams, with a trend observed toward a
lower velocity of relaxation (dP/dtmin, P .053), (Figure 3D).
The isolated Langendorff heart perfusion technique
also allowed us to measure cardiac responsiveness (chro-
notropic and inotropic) to parasympathetic and sympa-
thetic agents such as carbachol and isoprenaline, respec-
tively. The response to these drugs was assessed in a
dose-responsive manner. Hearts from offspring of obese
dams had a blunted chronotropic response to carbachol
(P .001), (Figure 4A). However, there was no difference
between groups on the chronotropic response to isopren-
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aline (Figure 4B). When expressed as a ratio of sympa-
thetic to parasympathetic chronotropic responses, hearts
from offspring of obese dams showed sympathetic dom-
inance (P  .05), (Figure 4C). These hearts also demon-
strated an attenuated inotropic response to carbachol
compared with controls (P  .001), (Figure 4D). How-
ever, administration of isoprenaline enhanced the inotro-
pic response in offspring of obese dams (P .001), (Figure
4E). Hence, the ratio of sympathetic to parasympathetic
inotropic responseswas alsomarkedly elevated compared
with controls (P .001), (Figure4F).These characteristics
define cardiac sympathetic dominance in offspring of
obese dams in relation to both the inotropic and chrono-
tropic response. It is therefore significant that long-term
cardiac activation by the sympathetic nervous system is
considered a surrogate marker of heart failure (31) as this
suggests that an overt sympathetic response provides ev-
idence that the hearts of these offspring are failing.
Figure 1. Offspring body weight and cardiac morphometry (3, 5, 8, and 12 wk of age). A, Growth trajectory. B, Absolute heart weight. C) Cross-
sectional cardiomyocyte cell area. D) Representative images of cardiomyocyte cell borders stained with wheat germ agglutinin. Control offspring
(E or white bars) and OffOb offspring (f or black bars). For offspring growth trajectory from day 3–21, controls, n  31; OffOb, n  38. From day
21–35, controls, n  29; OffOb, n  26. From day 35–56, controls, n  20; OffOb, n  20. From day 56–84, controls, n  9; OffOb, n  7.
Sample number is represented inside the histogram and data are presented as mean  SEM. Effect of maternal diet and age is marked as , P
 .001. Between-group comparisons are represented by asterisks, **, P  .01; ***, P  .001. For within-group comparisons, different letters are
significantly different from each other (P  .05).
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Cardiac dysfunction and sympathetic dominance in
offspring of obese dams could be explained by
the down-regulation of SERCA2a and
up-regulation of 1 adrenergic receptors
To address the possible cause of both the sympathetic
dominance and cardiac dysfunction, proteins involved in
the cardiac contractile machinery, diastolic function, and
sympathetic tone were measured in offspring at 12 weeks
of age.1 adrenergic receptors are themostpredominantly
expressed subtype in the murine heart (32). Furthermore,
they have an important role in both the chronotropic and
inotropic response to sympathetic stimulation (33, 34)
and are involved in calcium mobilization. Concurrent
with the functional sympathetic dominance, protein levels
of the 1 adrenergic receptor were increased in hearts of
offspring of obese dams (Figure 5A). However, the dimin-
ishedparasympathetic response inoffspringofobesedams
was not accompanied by differences in muscarinic type
2-acetylcholine receptor levels (Figure 5B), the predomi-
nant subtype associated with the parasympathetic re-
sponse in the heart.
Defects in cardiacmyofilaments are alsoknown tohave
a role in cardiac disease (35, 36). Cardiac phosphorylated
troponin-I (serine 23/24) (P  .05) and total troponin-I
(P  .05) were significantly reduced in offspring from
obese dams (Figure 6, A and B). In a cardiac-specific tro-
ponin-I knockout mouse model, loss of troponin-I was
compensated for by its fetal isoform up to 15 days of age.
However, long-term compensation was not maintained
and mice developed heart failure at 18 days of age (37).
This highlights the importance of troponin-I for cardiac
function and suggests that a reduction of troponin-I in
offspring of obese dams may impair cardiac function.
However the ratio of phosphorylated to total troponin-I
between groups was not different (controls, 100  19%
controlmean vsOffOb90 23%controlmean;P .74).
There was also no difference in the protein levels of tro-
pomyosin (controls, 100  11% control mean vs OffOb
64  17% control mean; P  .13). Sarco/endoplasmic
reticulum Ca2 ATPase (SERCA2a) is important for ex-
trusion of cytosolic calcium necessary for cardiomyocyte
relaxation as well as in accumulating calcium in the sar-
coplasmic reticulum in preparation for contraction (38).
Protein levels of SERCA2a were attenuated (P  .05) in
offspringofobesedams (Figure6C).Thisprovides amech-
anism for both impaired systolic and diastolic function in
these offspring.
Discussion
Our study has shown that exposure to maternal diet-in-
duced obesity during pregnancy and lactation leads to car-
diac hypertrophy and dysfunction in young adult mouse
Table 1. Circulating Factors in Offspring at 3, 5, and 8 Weeks of Age
Week 3 Week 5 Week 8
Control OffOb Control OffOb Control OffOb
Total cholesterol, mmol/La 2.44  0.15 2.62  0.40 3.75  0.09 3.42  0.22 3.22  0.12 3.33  0.12
Triglycerides, mmol/L 0.78  0.10 1.20  0.07 0.88  0.05 1.83  0.74 1.73  0.18 1.58  0.20
Free fatty acids, mol/La 947  73 813  87 1577  175 1555  200 878  1 831  90
a Significant overall effect of age. 3, 5, and 8 weeks of age; controls, n  10; OffOb, n  10.
Table 2. Cardiac Parameters in Offspring at 3, 5, 8, and 12 Weeks of Age
Measurements
Week 3 Week 5 Week 8 Week 12
n n n n
Heart weight:body weighta,b
Control 0.65  0.02 12 0.65  0.02 10 0.61  0.02 12 0.62  0.03 8
OffOb 1.05  0.04*** 12 0.74  0.03 12 0.73  0.03* 10 0.62  0.02 7
LV volume (mm3)a,b
Control 14.33  0.88 9 27.77  0.61 8 28.53  1.32 8 29.54  2.49 9
OffOb 21.53  1.03* 8 34.66  1.64* 8 32.80  2.03 7 32.67  0.59 7
RV volume (mm3)a,b
Control 2.07  0.08 9 2.95  0.10 8 7.06  0.41 8 6.33  0.63 9
OffOb 2.81  0.18 8 3.52  0.10* 8 6.50  0.27 7 7.29  0.54 7
a Significant overall effect of maternal diet.
b Significant overall effect of age.
Between-group comparisons are represented by asterisks, *, P  .05 and ***, P  .001.
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offspring, independent of offspring body weight and ad-
iposity at 12weeks of age. It also clearly demonstrates that
cardiac hypertrophy is a very early consequence of mater-
nal diet-induced obesity, apparent from as early as wean-
ing and accompanied by substantial cardiac dysfunction.
Pathologic cardiac hypertrophy is often characterized
by re-expression of genes usually only expressed during
fetal life (39). There was evidence of re-expression of such
genes in offspring of obese dams compared with controls.
NPPB encodes brain natriuretic peptide (BNP) and is a
well-established serum marker used in the prognosis of
heart failure in the clinic (40, 41). BNP is a vasoactive
peptide released with the aim of reducing blood pressure
and/or volume in response to an increase in cardiacmuscle
stretch (42). The increased levels of NPPB transcript in
offspring of obese dams, particularly at 3 weeks of age
suggests a compensatory response to increased cardiomy-
ocyte muscle stretch. Re-expression of ACTA1 that en-
codes-smoothmuscle actin has been associatedwith car-
diac hypertrophy in vitro and in vivo, in animal models
and humans (43, 44). Increased transcript levels of
ACTA1was seen at 3 and 12weeks of age, with the great-
est difference observed at 3 weeks of age. Elevated
-smooth muscle actin is associated with a rapid increase
in heart volumeandpositively correlateswith cardiac con-
tractility in humans and animal models (44, 45). There-
fore, increasedACTA1acts as a compensatorymechanism
to increase the contractile capacity of the heart in response
toan increase involume (46).This couldbe themechanism
adopted in the hearts of offspring of obese dams, whereby
the greatest increase inACTA1 transcript was observed at
3 weeks, the age at which there was the greatest difference
in heart weight between groups. In the mouse heart there
is a predominance of -myosin heavy chain (MHC), en-
coded by theMYH6 gene, and is known as the fast twitch
fiber due to its higher ATPase capacity (27, 28, 47). By 3
weeks of age there was a switch in the ratio of MHC to
favor the slow twitch -MHC in offspring of obese dams.
A switch in the ratio of these isoforms could act to preserve
energy in response to pathologic heart stress; however,
although initially conserving energy, a long-term switch is
associated with cardiac dysfunction (28, 48). Changes in
the ratio of MHC are directly proportional to the perfor-
mance and efficiency of the heart (49); therefore, these
changes are consistent with the observed cardiac dysfunc-
tion in the offspring of obese dams.
Offspring of obese dams showed systolic and diastolic
dysfunction, with evidence of im-
paired ventricular contractility and
reduced myocardial compliance.
SERCA2a removes cytosolic cal-
cium required for cardiomyoycte re-
laxation, while accumulating cal-
cium in the sarcoplasmic reticulum
in preparation for contraction.
Therefore, reduced SERCA2a could
explain both the systolic and dia-
stolic dysfunction in offspring of
obese dams. Reduced expression of
SERCA2a has been associated with
cardiac dysfunction, ischemia-reper-
Figure 2. Offspring fetal gene expression (relative mRNA levels normalized to PPIA) at 3, 5, 8, and 12 wk of age. A, NPPB; B, ACTA1; C, MYH7:
MYH6. Control offspring (white bars) and OffOb offspring (black bars). Sample number is represented inside the histogram and data are presented
as mean  SEM. Overall effect of maternal diet and age is signified by, , P  .05; , P  .01; , P  .001. Between-group comparisons
are represented by asterisks, *, P  .05.
Figure 3. Offspring baseline cardiac function at 12 wk of age. A, LVDP; B, dP/dtmax; C,
LVEDP. D) dP/dtmin. Control offspring (white bars) and OffOb offspring (black bars). Sample
number is represented inside the histogram and data are presented as mean  SEM, *, P 
.05; **, P  .01.
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fusion injury, and heart failure (50–52). Furthermore,
these offspring also showed reduced protein expression of
total troponin-I that plays an important role in normal
cardiac function. In a cardiac-specific knockout mouse
model, loss of adult troponin-I was initially compensated
for by the fetal isoform. However, long-term compensa-
tion was not maintained and mice developed heart failure
(37). Differences in the phosphorylation of myofilament
troponin-I have been observed between healthy and fail-
ing hearts (53, 54). Whereas absolute phosphorylation
levels of troponin-I (serine 23/24) were reduced in off-
spring of obese dams, there was no difference between
groups when normalized to total levels.
In offspring of obese dams, systolic and diastolic dys-
function was associated with cardiac sympathetic domi-
nance. Elevated LV end diastolic pressure is itself associ-
ated with increased mortality (55). Cardiac sympathetic
dominance is adaptive and aimed at maintaining cardiac
output. However, heightened cardiac sympathetic excita-
tion coupledwith diminished cardiac parasympathetic re-
activity have been associated with CVD, being an unsus-
tainable condition, and leading to eventual heart failure
(31, 56). The increased sympathetic dominance in the off-
spring of obese dams can be explained by up-regulation of
1 adrenergic receptors. The etiology underlying the at-
tenuated parasympathetic responsiveness in the hearts of
offspring of obese dams may be receptor independent
given that there were no differences in the protein expres-
sion of the predominant muscarinic (M2) acetylcholine
receptorbetweengroups.Thismay suggest apotential role
of effectors downstream of theM2 acetylcholine receptor
including Gi activity, adenylyl cylase, phospholipase C,
Figure 4. Chronotropic and inotropic response to increasing doses of carbachol (109–107 M) and isoprenaline (1010–108 M) in offspring at
12 wk of age. A and B, Chronotropic response. C, Sympathetic:parasympathetic ratio for HR. D and E, Inotropic response. F,
Sympathetic:parasympathetic ratio for LVDP. Control offspring (E or white bars) and OffOb offspring (f or black bars). Sample number is
represented inside the histogram or on the figure legend, and data are presented as mean  SEM. Overall effect of maternal diet and dose is
signified by, , P  .001. Between-group comparisons are represented by asterisks, *, P  .05; ***, P  .001. For within-group comparisons,
different letters are significantly different from each other (P  .05).
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potassium channels, and protein tyrosine kinases [re-
viewed in (57)].
Notably, cardiac dysfunction was present at 12
weeks of age when the cellular and structural phenotype
of cardiac hypertrophy was no longer apparent. Al-
though cardiac hypertrophy acts as a protective mech-
anism, it is well understood that this phenotype cannot
be maintained long-term. Therefore, we hypothesize
that at 12 weeks of age cardiac hypertrophy is subsiding
because the heart is no longer able to sustain adequate
cardiac function. Based on the Langendorff data that
showed cardiac sympathetic dominance in offspring of
obese dams (a pre-eminent marker of heart failure) with
age (31), these offspring may be on the pathway to pre-
mature heart failure. The potential for heart failure in
these offspring is supported by the Langendorff data,
which show impaired systolic function and LV stiffen-
ing in young adulthood.
Potential underlying mechanisms through which car-
diac hypertrophy and cardiac dysfunction may arise have
been suggested by previous molecular studies. One study,
using the same mouse model, showed that hyperinsulin-
emia in offspring of obese dams was associated with in-
creasedaction throughboth thephosphoinositide3kinase
andmitogen-activated protein kinase pathways in cardiac
tissue (13). Both of these pathways have been associated
with cardiac hypertrophy. Furthermore, offspring of
obese dams had increased p38MAPK, a marker of path-
ological cardiac hypertrophy (58). Oxidative stress has
also been implicated in a variety of programming models
as a potential mechanism underlying developmental pro-
gramming in the offspring. Offspring of obese dams at 8
weeks of age had increased lipid peroxidation, impaired
antioxidant capacity, and an increased potential for the
generation of superoxide (13). A model of maternal hyp-
oxia in rodents has also been associated with enhanced
oxidative stress in both the fetal heart and vasculature at
4 months of age (23). Furthermore, the adverse effects of
maternal hypoxia on the offspring cardiovascular system
were prevented by maternal treatment with the antioxi-
dant Vitamin C (23). In a sheep model of maternal over-
nutrition, increased levels of oxidative stresswere found in
fetal tissues accompanied by an impaired response to
workload stress (15). Oxidative stress has therefore been
implicated in a variety of developmental programming
models, suggesting that it may be a common mechanism
underlying the programming of CVD by a range of sub-
optimal early life exposures.
We conclude that cardiac hypertrophy is a very early con-
sequence of maternal diet-induced obesity that is associated
with impaired systolic and diastolic function in young-adult
offspring of obese dams. Importantly,
these changeswere independentofdif-
ferences in offspring body weight.
These findings therefore provide a po-
tentialmechanistic basis to explain re-
cent human observations linking ma-
ternalobesitytoprematuredeathfrom
CVD. In light of the growing epidemic
of obesity worldwide, these findings
have major implications for the long-
term cardiovascular health of children
today. Furthermore, understandingof
the mechanisms mediating the effects
of maternal obesity on offspring car-
diac function is therefore urgently
needed.
Figure 6. Protein expression of contractile proteins expressed relative to control offspring. A)
Phospho-troponin-I (serine 23/24) (28 kDa). B) Total troponin-I (29 kDa). C) SERCA2a (114 kDa).
Control offspring (white bars) and OffOb offspring (black bars). Sample number is represented
inside the histogram and data are presented as mean  SEM, *, P  .05. Blots shown below the
histograms are from the same gel.
Figure 5. Protein expression of receptors expressed relative to control
offspring. A) 1 adrenergic receptor (50 kDa). B) Muscarinic type-2
acetylcholine receptor (64 kDa). Control offspring (white bars) and
OffOb offspring (black bars). Sample number is represented inside the
histogram and data are presented as mean  SEM, **, P  .01. Blots
shown below the histograms are from the same gel.
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